• The company’s new system focuses on the science behind unique combinations of THC and CBD
• The intent of the new system is to reduce consumer confusion related to cannabis products
• PLUS cannabis products were top sellers in California over the past 12 months

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a manufacturer and marketer of cannabis food products, has rebranded its line of low-dosage, cannabis-infused edibles. The goal behind the new look is to ensure clarity and differentiation to its Uplift, Balance and Unwind lines for consumers (http://ibn.fm/sbdJU).

The new look includes three easy-to-understand banners and colors for the brand, which are designed to eliminate any confusion consumers have between the Uplift, Balance and Unwind cannabis edibles lines. PLUS cannabis edibles are available at more than 300 licensed retailers in California. In addition, PLUS edibles will be available at licensed retailers in Nevada by the end of the summer, the company said.

“Cannabis can be confusing,” PLUS CEO and co-founder Jake Heimark stated in a news release. “We hope our new system will help reduce some of that confusion. We worked with experienced market researchers to find out why people use cannabis, then translated those findings into an easy-to-use system of cannabis. We are excited to help our customers Uplift their experiences, bring Balance to their everyday and Unwind without getting unwound.”

PLUS has instituted a new look for this product line that offers a clear differentiation. The rebrand research was performed by Henry J. Rak Associates, and the new look was designed by agency Partners & Spade, the company said. The goal for the rebranding is to create the right mix of cannabinoids paired with a targeted flavor profile to give the customer an amazing product experience.

“We believe this system will make PLUS even more accessible to new consumers,” Heimark added. “And we hope our investments in consistency and quality will keep them coming back.” PLUS said that the new product and packaging system focuses on the science behind unique combinations of THC and CBD.

PLUS had the top two best-selling cannabis products in California over the past 12 months, in terms of units and retail dollars sold, according to the BDS Analytics’ GreenEdge Retail Sales Tracking Platform.

San Mateo, California-based PLUS is a cannabis-infused, branded products manufacturer selling to regulated medicinal and adult-use recreational markets in California and Nevada. PLUS is focused on building the largest cannabis brand by growing organically and through acquisitions.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• Record sales attributed to DVLP’s operational entity and subsidiaries
• CEO says that DVLP has built a diverse ecosystem of products and services and is creating a community of consumers and businesses in the cannabis space
• The company’s new 25,000-square-foot facility is expected to “exponentially amplify” its manufacturing capabilities

Golden Developing Solutions Inc. (OTC: DVLP) reported sales of $1,965,641 for Q2 2019, ended June 30. DVLP is an early-stage emerging company offering business services and/or products supporting the cannabis industry. The company’s portfolio includes several fully owned ancillary technology, CBD and cannabis businesses (http://ibn.fm/iUHZZ).

“We believe our diverse ecosystem of product and service offerings is creating a community of consumers and businesses,” DVLP CEO Stavros Triant stated in a news release. “It’s also successfully fulfilling needs across multiple channels of the cannabis and cannabis-related industries that weren’t previously available or developed.”

The company secured a new 25,000-square-foot facility in Denver, Colorado, in early June. DVLP expects (http://ibn.fm/mJwdZ) the facility to “exponentially amplify (its) manufacturing capacities in the future.” Triant added that, while the firm is increasing its manufacturing capability, it is also focused on building vertical management.

“We’ve built a technical foundation, and now we’re working to solidify a team to support it,” Triant added. “With leaders in varying verticals applying themselves across multiple brands, we’re not surprised to see the increased second-quarter sales figures.”

This multitiered strategy also drove the company’s recent acquisition of Infusionz LLC. This subsidiary offers online retail sales of cannabidiol (CBD), hemp oil, health and wellness-related products, and direct-to-retail wholesale products. These products include CBD-based tinctures, vapes, soft gels, traditional vitamins, supplements and more.

DVLP achieved fully reporting status through its filing of a Form 10 Registration Statement with the SEC, effective July 1. The filing ensures continued transparency with current and future investors. DVLP will file all detailed and audited financial statements, reports, policies and potential risk factors. It will also file a full 10K annual report for the year ended December 31, 2019 (http://ibn.fm/mWFbR).

For more information, visit the company’s website at www.GoldenDeveloping.com

NOTE TO INVESTORS: The latest news and updates relating to DVLP are available in the company’s newsroom at http://ibn.fm/DVLP

• Organigram’s proprietary nano-emulsion technology is expected to provide an initial onset of effects within 10 to 15 minutes for cannabis beverages
• The company’s shelf-stable, thermally stable, water-compatible and palatable cannabinoid nano-emulsion formulation allows for the production of both liquid and powdered beverage products
• Organigram plans to launch dried powder formulation beverage products in early 2020

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), the parent company of leading licensed cannabis producer and cannabis-derived products manufacturer Organigram Inc., has developed a proprietary nano-emulsification technology. This new unique, fast-acting formulation will allow for the production of both powdered and liquid cannabinoid products. The development comes in the context of the much-anticipated legalization of adult recreational-use cannabis edibles in Canada and the ensuing boost in demand, as the company noted in a news release (http://ibn.fm/zy5Pt).

Organigram focuses on high-quality, indoor-grown cannabis for both medical patients and adult recreational users. Its proprietary technology allows for the development of products with a quick onset of the cannabinoid effect within 10 to 15 minutes. To determine the onset of the products, Organigram studied cannabinoid particles at a size of 20 nanometers. Organigram’s nano-emulsion technology is stable to temperature variations, mechanical disturbance, salinity, pH and sweeteners. Further testing is anticipated to occur in order to confirm the onset of action and the duration of the effect.

Previously, Organigram announced the launch of premium cannabinoid-infused chocolates. The company will also be working toward the release of additional dried powder formulation beverages in Canada in early 2020.

“This is an exciting time for cannabis product makers”, Organigram CEO Greg Engel said in a news release. “To ensure the satisfaction of adult consumers, companies have to deliver both predictability and reliability. Organigram’s technology and the powdered formulation put the customer in control, allowing them to infuse just about any beverage… This new method of delivery allows for a completely new experience.”

At the same time, Organigram is also actively seeking a partner with proven experience within the beverage market to take advantage of the liquid formulation it has developed.

On July 10, Organigram announced a collaboration with Lift & Co. Corp. (TSX.V: LIFT) (OTCQB: LFCOF), supporting the launch of Canada’s first branded cannabis educational program (http://ibn.fm/KEQiK).

The program, developed in partnership with MADD Canada, aims to promote the responsible sale of cannabis and will be available via the Lift & Co. CannSell retail training program. Currently, CannSell is the only mandatory, provincially approved cannabis training program for all Ontario retail workers. Organigram is the first licensed cannabis producer in Canada to partner up with Lift & Co. for the purpose of educational content creation.

The rollout of the branded Organigram module of the program started in June 2019. The module will deliver digital training on Organigram’s three-tiered growing methodology, as well as best practices.

“This module will allow Organigram to connect directly with budtenders at any time and educate retail staff about their product attributes, best practices and stay top-of-mind with budtenders – the only people in the value chain speaking directly with consumers,” Lift & Co CEO Matei Olaru added.

For more information, visit the company’s website at www.Organigram.ca

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://ibn.fm/OGRMF

• Marijuana Company of America has begun accepting signups for its San Fernando Valley-based Viva Buds cannabis delivery venture as the official August launch draws near
• Viva Buds offers consumers the opportunity to not only receive cannabis products at a low market price but also to earn income from referring the service to others
• MCOA recently announced an LOI for a joint venture designed as a large farming operation for hemp-based CBD production, extractions and sales

Marijuana Company of America Inc. (OTCQB: MCOA) continues to build steam in its efforts to light up the enormous California cannabis market, announcing an expanded hempSMART product line and the prelaunch of signups for its premier cannabis distribution service and home cannabis business fostering strategy.

MCOA announced during the spring that it would partner with Natural Plant Extracts of California to form the joint venture Viva Buds, a Southern California tetrahydrocannabinol (THC)-based cannabis delivery service that will offer customers a line of high-quality products at low prices, with the added benefit of being able to build their own personal cannabis businesses if they wish (http://ibn.fm/tphFV).

More recently, MCOA announced plans to form an additional JV with Essence Farms LLC that will create the Riverside Hemp Project to grow, cultivate, manufacture, extract and sell legal hemp and hemp-derived cannabidiol (CBD) on a large California farming operation (http://ibn.fm/2h9tY).

The company’s hempSMART brand provides wellness industry consumers with full-spectrum, natural extracts designed to support the body’s endocannabinoid system in balancing cells and systems of the human body. The just-launched hempSMART Body Cream product is the latest addition to the lineup, formulated with 300mg of organically grown, full-spectrum, non-psychoactive CBD to replenish, restore and rejuvenate skin cells for improved elasticity, supple texture and healthy radiance (http://ibn.fm/8fPl9).

“The new hempSMART Body Cream is a major advancement in the wellness arena,” hempSMART Medical Advisory Board Chairwoman Paula Vetter stated in a news release. “The cream is completely free of toxins that are commonly found in many skin care products and absorbed through the skin and into the blood stream. Instead, hempSMART’s Body Cream is a topical wellness solution that sets a new standard in the industry by improving the overall health of skin with each use.”

The announcement states that the cream’s formulation is rich in omegas 3, 6, 7 and 9, along with naturally occurring plant ceramides to build a strong and vibrant cellular matrix deep within skin layers, and it includes botanicals such as organic aloe, sacha inchi oil, argan kernel oil, macadamia nut oil, rose hip seed oil, frankincense, tulsi, pomegranate seed oil, ashwagandha, turmeric oil, coconut oil and sea buckthorn oil.

The hempSMART brand was the key to driving the company’s 840 percent year-over-year increase in total revenues last year (http://ibn.fm/SD9Yf). Gross profits increased from a 47 percent gross margin to a 68 percent gross margin during the year, while the company’s net loss from operations dropped by 82 percent.

The company’s Viva Buds venture is getting on its feet in the San Fernando Valley, with a live virtual launch party anticipated for August 9 to mark the official commencement of its operations. The beginning of signups for its delivery service through its web portal allows customers the opportunity to make referrals prelaunch and use the “call your friend” approach to building their own businesses.

“We are excited to be a partner in what we believe will be a game changing and disruptive delivery model in the marketplace,” Natural Plant Extracts of California CEO Alan Tsai added. “We offer an incentivized program that is mutually beneficial for our customers as well as the company.”

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• ETST subsidiary CTI is engaged in the research and development of cannabidiol
• The company has partnered with Canna Inno Laboratories Inc. to strengthen its foothold in the Canadian CBD market
• ETST’s Earth Science Pharma is working to develop and bring to market medical devices and vaccines specifically designed for women

Earth Science Tech Inc. (OTCQB: ETST), headquartered in Doral, Florida, is an innovative biotech enterprise that offers CBD in the forms of vitamins, minerals, herbs, botanicals, personal-care products, homeopathies, functional foods and other products. Through its wholly owned subsidiaries, the company operates in the fields of hemp cannabinoids, nutraceuticals, pharmaceuticals, medical devices, and research and development.

ETST’s subsidiaries focus on developing roles as international leaders in the CBD arena:

• Cannabis Therapeutics Inc. (“CTI”) is an emerging biotechnology company that has ventured into the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and leverage the medicinal power of cannabidiol (http://ibn.fm/CDayh).
• Canna Inno Laboratories Inc. was formed by Earth Science Tech in 2017 as a strategic Montreal, Canada-based company to give ETST a foothold in Québec and provide the company with access to government grants, the first of which have just been approved (http://ibn.fm/jphlA).
• Earth Science Pharma Inc. is an emerging medical research company dedicated to developing leading-edge medical devices and vaccines that will improve the health of women around the world. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs such as chlamydia from a self-obtained gynecological specimen (http://ibn.fm/mAPZk).

In addition to the powerful global presence ETST’s subsidiaries are creating, ETST itself is working within the space. The company has partnered with the University of Central Oklahoma and DV Biologics Laboratory to work on projects that scientifically support and advance the health care benefits of its high-grade hemp CBD oil. Made using the supercritical CO2 liquid extraction process, ETST products deliver high purity, top quality full-spectrum cannabinoid oil (http://ibn.fm/XL1f6).

In addition, Earth Science Tech has agreements with CannaBiz and Desert Sun Distribution to distribute the company’s high-grade, full-spectrum cannabinoids line throughout pharmacies, chiropractors, dispensaries, athletic clubs and clinics in the United States (http://ibn.fm/R5wH5).

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• A reversal of the federal ban on the use of controversial pesticides linked to potential health disorders illustrates a pressing need for MustGrow’s patented technology for natural biopesticide solutions
• MustGrow’s research and development program focuses on a portfolio of natural biopesticides and biofertilizers, and it is expanding into the cannabis and tobacco industries
• Global crop protection is a multibillion-dollar market that’s expected to surge over the next five years

The Environmental Protection Agency’s recent decision to allow the use of two chemical pesticides – chlorpyrifos and sulfoxaflor, both made by Corteva Agriscience, formerly part of DowDuPont – highlights the importance of research into safe, natural biopesticides such as those now under development by MustGrow Biologics Corp. (CSE: MGRO).

Numerous organizations are pushing to ban the pesticides as harmful substances to humans and other living creatures. According to Reuters, studies show that exposure to chlorpyrifos is linked to low birth weight, reduced IQ, attention disorders and other issues in infants and children (http://ibn.fm/RvwlO). Likewise, The Associated Press reports that the use of sulfoxaflor is decimating beneficial insects such as the honeybee (http://ibn.fm/hQVwQ).

Agricultural biotech company MustGrow Biologics is developing and commercializing a portfolio of natural biopesticides and biofertilizers that may provide high quality, organic pest control to growers facing soil-borne diseases and pests that ruin crops, including those in the cannabis and tobacco industries. MustGrow’s patented products are refined from compounds of the mustard plant, utilizing the plant’s natural defense mechanism as a pre-plant soil biopesticide treatment (http://ibn.fm/RhJAF).

MustGrow’s signature products are shown to deliver effective pathogen and pest control to ensure plant growth and high yields in a variety of agricultural settings (http://ibn.fm/7JqnU). MustGrow is also testing the potential application of its technology in the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020, and for nematode biocontrol in the global tobacco industry.

Previous research findings made in collaboration with Virginia Tech’s Southern Piedmont Agricultural Research and Extension Center on the safety and efficacy of MustGrow’s patented granular organic biopesticide as a natural pre-plant soil treatment are encouraging, leading to a new research program, according to a news release (http://ibn.fm/GIIq6). The R&D effort targets tobacco cyst nematodes, a parasitic ringworm that has been reported in 11 tobacco-producing countries on four continents.

Based on MustGrow’s promising scientific achievements and research, advance corporate collaboration discussions are now underway with tobacco industry leaders. The recent appointment of Altria Group veteran Brian Quigley to MustGrow’s board of directors illustrates the company’s belief that there is significant opportunity to seek approval of MustGrow’s second generation liquid technology as an organic biopesticide for eventual use by tobacco growers (http://ibn.fm/Ymlqh).

For more information, visit the company’s website at www.MustGrow.ca

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO

• Grapefruit has entered into a letter of intent with Dogwood Management Group Inc. to acquire and manage retail dispensaries in Northern and Southern California
• The company recently commenced retail sales of its first Grapefruit brand of cannabis-infused edible gummies under the trade name Sugar Stoned®
• Grapefruit is preparing to introduce more cannabis-infused offerings, including its new wellness and lifestyle brands line of CBD and THC mixed vaporizer cartridges, in Q3 2019
• Parent company Imaging3 Inc. plans to change its ticker symbol and corporate name in order to better reflect Grapefruit’s branding across its platforms

Grapefruit Boulevard Investments Inc., a California corporation and a wholly owned subsidiary of Imaging3 Inc. (OTCQB: IGNG), has entered into a letter of intent with Dogwood Management Group Inc. The nonbinding letter of intent outlines the agreement between the two companies: Grapefruit plans to acquire and Dogwood will manage California-licensed and fully compliant retail cannabis dispensaries throughout California that meet the regulatory, operational and financial results requirements for the two companies (http://ibn.fm/KTW7P).

“We continue to press purposefully forward toward our ultimate goal of vertical integration by implementing this initial program to build a network of fully compliant, legal dispensaries by entering into this arrangement with Dogwood which eliminates the necessity of building an in house acquisition staff and dispensary management team and thereby significantly accelerates our legal retail dispensary acquisition program,” Grapefruit CEO Bradley Yourist stated in a news release. “Dogwood’s CEO Steely Inoue and I, and our respective management teams, will work closely together over the coming months to identify, acquire and successfully manage various retail cannabis dispensaries in both Northern and Southern California. It has always been Grapefruit’s intent to become a fully vertically integrated, seed to sale cannabis and CBD company, and our new relationship with Dogwood Management advances that goal.”

Yourist described CEO Steely Inoue and his Dogwood management team as “true cannabis professionals” bringing a “complete turnkey retail dispensary management program” to Grapefruit. He praised Dogwood’s extensive experience in managing some of the highest-profile, most profitable dispensaries in California, which is home to one of the most competitive cannabis markets in the world.

Yourist concluded, “With this new collaboration between Dogwood and Grapefruit, we have set the stage for Grapefruit to quickly acquire legal, compliant and auditable retail locations in California to rapidly expand Grapefruit’s revenues.”

Grapefruit is poised to expand its laboratory extraction operations and distribution services throughout California. In June, the company commenced retail sales of its first brand of cannabis-infused edible gummies in the state under trade name Sugar Stoned (http://ibn.fm/GLSWc).

“Retail cannabis product consumers will be able to enjoy our Sugar Stoned infused gummies with the knowledge that Grapefruit products have been tested and are certified to be pesticide and heavy metal free by a third-party laboratory before being released at retail,” Yourist added (http://ibn.fm/cITZT).

Based in Westwood, California, Grapefruit is a manufacturer and distributor of various cannabis products and holds both a manufacturing and distribution license issued by the State of California.

For more information, visit the company’s website at www.GrapefruitBlvd.com

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://ibn.fm/IGNG

• PLUS Uplift and Restore products ranked as the two best-selling cannabis edibles in California in terms of both dollars and units sold
• Plus Products has expanded into Nevada through a definitive agreement with TapRoot Holdings Inc.
• Projections estimate that Nevada will surpass $700 million in cannabis sales by 2020

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a manufacturer and marketer of cannabis food products, is committed to ensuring the consistency of its products as it expands and sees continued success in the industry. PLUS co-founder and CEO Jake Heimark recently reiterated the company’s commitment to maintaining quality and consistency in PLUS products, wherever they are sold (http://ibn.fm/3xaUk).

BDS Analytics reported that, in Q1 2019 (the three months ended March 31), PLUS Uplift and PLUS Restore gummies were the two best-selling edible products in California in terms of both dollars and units sold (http://ibn.fm/xYXtH). PLUS Uplift brand owned 25 percent market share YTD in 2019, the company reported.

Building on its success in selling edible products in California, Plus Products has now entered Nevada, marking its first expansion outside California. The company is making this move through a definitive agreement with TapRoot Holdings Inc., a vertically integrated cannabis company operating cultivation and manufacturing facilities in Las Vegas.

“As we look to expand beyond California, we remain committed to producing a consistent product in all jurisdictions,” Heimark stated in a news release. “We want the PLUS customer to have the same experience with our products whether they buy it in LA or in Las Vegas.” The company will begin marketing its gummies and low-dose mints in Nevada dispensaries this summer.

An analysis article (http://ibn.fm/VdB6z) by Technical420 author Anthony Varrell calls the entry by Plus Products into Nevada a “growth driver” and deems Las Vegas a “key market to building an internationally recognized brand.” He cited the 45 million visitors to Las Vegas each year as an important factor in the move. Varrell also noted that Plus Products will be the manufacturing operations partner as it expands into new markets, ensuring quality and consistency. The article also included research by Arcview Market Research, combined with BDS Analytics, that projects retail sales of cannabis in Nevada to surpass $700 million by 2020.

San Mateo, California-based PLUS is a cannabis-infused, branded products manufacturer selling to regulated medicinal and adult-use recreational markets in California and Nevada. PLUS is focused on building the largest cannabis brand by growing organically and through acquisitions.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• Cannabis users have historically preferred to inhale smoke from the burned plant in order to achieve rapid-onset absorption of its properties, but Lexaria Bioscience is making it possible to achieve similar results through oral ingestion
• Lexaria’s revolutionary DehydraTECH technology allows cannabis users to eliminate the unhealthy effects of smoking from their routines, and the product is being tested with nicotine as well
• Cannabis-infused edibles sales are expected to climb from about $1 billion currently to about $4.1 billion by 2022

Consumable bioactive product innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) will expand the reach of its revolutionary DehydraTECH technology across the United States courtesy of a definitive five-year agreement that allows B2B hemp substance manufacturing firm Universal Hemp LLC to include it in many cannabidiol (CBD)-based food ingredients.

Lexaria’s DehydraTECH is an ingested drug delivery platform patented to work with all psychoactive and non-psychoactive cannabinoids (http://ibn.fm/qPDtt), making them bioavailable through absorption at a rate comparable to the rapid-onset effect of inhaled cannabis without the detrimental health effects that arise from smoking. The Lexaria technology accomplishes this by speeding the rate of absorption for chemicals in edibles – an otherwise slow means of making substances bioavailable through the bloodstream.

DehydraTECH also allows the substances to be ingested without the need for the unhealthy sweeteners that are commonly used in cannabis-infused products to mask bitter tastes, according to the company.

The Universal Hemp agreement packages DehydraTECH with food ingredients to be produced for the nutraceutical and consumer packaged goods industries. In addition to the United States, outlets in Canada will be included once that country’s regulations allow edible cannabis products.

“In terms of bioavailability, shelf stability and taste this is the best performing technology in the market, hands down. Our corporate customers cannot wait to put our water-soluble solution into their products!” Universal Hemp CEO and Founder Chad Kahunahana stated in a news release about the agreement (http://ibn.fm/SaAP7).

Chris Bunka, CEO of Lexaria Bioscience, noted that the agreement’s new inroads to the hemp industry will not only deliver rapid product uptake, but also allow the company to deliver precision dosing and maximum product strength. Cannabis industry publication Green Entrepreneur reported that cannabis-infused edibles sales reached over $1 billion in 2018 and are expected to amount to about $4.1 billion by 2022 (http://ibn.fm/Ew9jX), showing an exponential level of growth.

In addition, Lexaria also recently announced its entry into a CBD beverage license agreement with Nic’s Beverages LLC for use in CBD-based beverages to be produced and sold throughout the United States. Nic’s Beverages will initially produce ready-to-drink (RTD) cold brew coffees enhanced with CBD from multi-spectrum hemp oil (http://ibn.fm/HvuxQ).

Lexaria is the only company in the world to have a patent issued for the oral delivery of all cannabinoids. DehydraTECH has received 11 patents in the United States and Australia, and it has about 60 additional patents pending in more than 40 countries worldwide. The DehydraTECH platform has also been used in research on nicotine absorption (http://ibn.fm/0D8wB).

The company’s informative July 11 investor conference video on Virtual Investor Conferences’ series site is now accessible online, as noted in a news release (http://ibn.fm/ysLBZ).

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Plus Products is benefiting from new opportunities to expand its consumer base through the microdosing movement
• The company is moving toward establishing itself as a leading brand in the international market
• PLUS is exploring a rare opportunity to simultaneously improve quality control, cut costs and grow revenues through possible acquisition

Cannabis-infused products manufacturer Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) is creating edibles to support a health and active lifestyle for both new and veteran consumers. Drawing from more than 40 years of experience in food manufacturing, the company makes edibles from scratch using only the highest-quality extracts and kosher ingredients to create a consistent and delicious cannabis experience. To do this well requires foresight and the collaboration of a well-orchestrated team of experts across multiple fields. The PLUS team includes Michelin-star chefs, Ivy League chemists, food manufacturing experts, engineers, machinists, visionaries, creatives and strategists.

Seeking to strengthen its position, Plus Products moved to the largest cannabis market in the world — California — in 2015. From its 12,000-square-foot, food-safe, cannabis manufacturing facility in Adelanto, California, PLUS has set itself apart from the competition. In Q3 2018, PLUS(TM) was ranked the top edibles brand in California (http://ibn.fm/qDLju).

PLUS products are available in more than 200 licensed dispensaries and through delivery services across the state. The company is focused on building the largest cannabis brand through organic and acquisitional growth. In June, PLUS uplisted to the OTCQX Best Market.

Plus Products is continually looking toward new opportunities to expand its consumer base. This attention to rising opportunities is evident in a recent launch of a new product line that provides consumers with microdosing options (http://ibn.fm/Wzwis). The company’s commitment to quality and consistency builds trust with consumers who know what to expect from every PLUS gummy and mint.

The new microdosing mints provide consumers with the same exceptional culinary commitment, unique flavors and controlled dosage as the gummies. In addition, the microdosing option allows consumers to add cannabis into their healthy lifestyles at a lower dose, making PLUS even more approachable and convenient. PLUS Classic Mints, which are packaged in a child-resistant tin, provide 2.5 mg THC with less than 0.1 mg CBD.

Along with the release of its microdosing mints, PLUS expanded into the Nevada cannabis market through a definitive partnership agreement with TapRoot Holdings Inc. Both the gummies and the mints are now available in Nevada dispensaries. The company sees this new venture as a key component to building an internationally recognized brand. Nevada, a state that sees 45 million visitors a year from all over the world, is anticipated to surpass $700 million in cannabis retail sales in 2020 (http://ibn.fm/fUlOx).

In addition, PLUS is currently exploring a purchased option to buy Emerald Bay Wellness LLC and the business assets of Emerald Bay Extracts. The option grants Plus Products the right to buy, but not the obligation, as the company explores the acquisition. Emerald Bay is one of PLUS’ largest suppliers of cannabis oil.

If the company moves forward with the purchase, the strategic move is expected to provide PLUS with in-house cannabis extraction capabilities that would improve quality control, increase gross margin and create a new revenue stream and product-development capabilities (http://ibn.fm/lke79). PLUS co-founder and CEO Jake Heimark pointed out that the acquisition would provide the company with direct interaction with the cannabis plant and the ability to explore the many benefits associated with the crop.

Emerald Bay’s professionalism and expertise regarding rapid scalability has the potential to flourish under the umbrella of PLUS’ resources. “Ultimately, this is a rare opportunity to improve quality control, cut costs and grow revenues all at the same time,” Heimark stated in a news release.

As PLUS looks to the future, one thing is certain: the company is committed to making cannabis safe and approachable for all types of consumers by providing consistent, dosable, delicious products that stand out from the competition.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF